Rentschler Biopharma SE

Form 483

Laupheim, -, GermanyFEI 1000291122Issued December 06, 2016

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1000291122.

Observations1

Issue DateDecember 06, 2016

StatusNo Warning Letter

Related Inspections7

Establishment Details

Firm: Rentschler Biopharma SE
Location: Laupheim, -, Germany
FEI Number: 1000291122
Product Type: Drugs
Issue Date: December 06, 2016
Country: Germany

Inspection History, 2011 to 2023

NAI1

VAI6

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Rentschler Biopharma SE FDA Form 483, Laupheim, December 6, 2016